The global clinical laboratory services market size is expected to reach around US$ 293.6 billion by 2030 from US$ 205.49 billion in 2021 and is expected to grow at an impressive double-digit rate of 4.04% from 2022 to 2030.
The growing number of clinical trials and research and development activities in the healthcare industry are driving the global clinical laboratory services market. The rising frequency of targeted disorders around the world is one of the major factors driving the global clinical laboratory services market.
The study includes drivers and restraints of this market. The study provides an analysis of the global clinical laboratory services market for the period 2017-2030, wherein 2022 to 2030 is the forecast period and 2021 is considered as the base year.
Our Free Sample Reports Includes:
- In-depth Industry Analysis, Introduction, Overview, and COVID-19 Pandemic Outbreak.
- Impact Analysis 180+ Pages Research Report (Including latest research).
- Provide chapter-wise guidance on request 2022 Updated Regional Analysis with Graphical Representation of Trends, Size, & Share, Includes Updated List of figures and tables.
- Updated Report Includes Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis by using Precedence Research methodology.
Download Free Sample Copy Here (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1627
Research Methodology
A unique research methodology has been utilized to conduct comprehensive research on the growth of the global clinical laboratory services market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the draw conclusions. Secondary sources referred to by analysts during the production of the global market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.
These primary and secondary sources provided exclusive information during interviews, which serves as a validation from mattress topper industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global clinical laboratory services market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped to estimates the future prospects of the global market more reliable and accurate.
Why should you invest in this report?
If you are aiming to enter the global clinical laboratory services market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for clinical laboratory services are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global clinical laboratory services market include:
- Charles River Laboratories International Inc.
- Laboratory Corporation of America Holdings
- NeoGenomics Laboratories Inc.
- Siemens Healthcare GmbH
- Quest Diagnostics Inc.
- Fresenius Medical Care
- Viapath Group LLP
- Almac Group
- Sonic Healthcare
- OPKO Health Inc.
Market Segmentation:
By Test Type
- Human and Tumor Genetics
- Clinical Chemistry
- Medical Microbiology and Cytology
- Genetic Testing
- Drug of Abuse Testing
- Other Esoteric Tests
By Service Provider
- Hospital based laboratories
- Standalone laboratories
- Clinic based laboratories
By Application
- Bioanalytical and Lab Chemistry Services
- Toxicology Testing Services
- Cell and Gene Therapy Related Services
- Preclinical and Clinical Trial Related Services
- Drug Discovery and Development Related Services
- Others
Regional Analysis:
The geographical analysis of the global clinical laboratory services market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global clinical laboratory services Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global clinical laboratory services market in 2030?
- What is the expected CAGR for the clinical laboratory services market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global clinical laboratory services market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Clinical Laboratory Services Market
5.1. COVID-19 Landscape: Clinical Laboratory Services Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Clinical Laboratory Services Market, By Test Type
8.1. Clinical Laboratory Services Market, by Test Type Type, 2022-2030
8.1.1. Human and Tumor Genetics
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Clinical Chemistry
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Medical Microbiology and Cytology
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Genetic Testing
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Drug of Abuse Testing
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Other Esoteric Tests
8.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Clinical Laboratory Services Market, By Application
9.1. Clinical Laboratory Services Market, by Application, 2022-2030
9.1.1. Bioanalytical and Lab Chemistry Services
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Toxicology Testing Services
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Cell and Gene Therapy Related Services
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Preclinical and Clinical Trial Related Services
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Drug Discovery and Development Related Services
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Clinical Laboratory Services Market, By Service Provider
10.1. Clinical Laboratory Services Market, by Service Provider, 2022-2030
10.1.1. Hospital based laboratories
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Standalone laboratories
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Clinic based laboratories
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Clinical Laboratory Services Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.1.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.4.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.2.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.4.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.3.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.4.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.4.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.4.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Service Provider (2017-2030)
Chapter 12. Company Profiles
12.1. Charles River Laboratories International Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Laboratory Corporation of America Holdings
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. NeoGenomics Laboratories Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Siemens Healthcare GmbH
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Quest Diagnostics Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Fresenius Medical Care
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Viapath Group LLP
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Almac Group
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Sonic Healthcare
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. OPKO Health Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1627
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
0 Comments